Ropes & Gray Represents EQRx in Evotec Drug Discovery and Development Partnership
Ropes & Gray advised EQRx in a partnership to leverage Germany-based Evotec’s data-driven integrated drug discovery and development platform across different drug modalities and therapeutic areas in oncology and immunology. The transaction was announced on November 18.
Under the agreement, EQRx and Evotec will collaborate on drug discovery and pre-clinical development, while EQRx will be responsible for clinical development, regulatory and commercialization efforts.
The Ropes & Gray team was led by life sciences partner Abigail Gregor (Boston).